Duke Street Bio granted approval by European Medicines Agency to launch next-generation PARP1-selective inhibitor trial
September 24, 2024

September 24, 2024
May 15, 2024
May 14, 2024
May 8, 2024
May 6, 2024
February 21, 2024
February 20, 2024
February 5, 2024
February 5, 2024
August 11, 2026
Sciensus, one of the UK's largest providers of home-based healthcare, today announced a new agreement with global oncology company Novocure to deliver...
August 10, 2026
Accreditation strengthens ECI’s ability to provide trusted laboratory testing and integrated support to life sciences organizations ECI announced toda...
August 6, 2026
Tempus joins as a second commercial laboratory partnership to support oncology-focused access within CellCarta’s CDx Accelerator Model. CellCarta, a g...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225